Anticancer drug therapy for patients with renal dysfunction
K Suyama, Y Miura - International Journal of Clinical Oncology, 2023 - Springer
Anticancer drug therapy for cancer is developing rapidly, including molecular-targeted drugs
and immune checkpoint inhibitors that are used in clinical settings in addition to …
and immune checkpoint inhibitors that are used in clinical settings in addition to …
Anticancer drug therapy for patients with renal dysfunction
K Suyama, Y Miura - International journal of clinical …, 2023 - pubmed.ncbi.nlm.nih.gov
Anticancer drug therapy for cancer is developing rapidly, including molecular-targeted drugs
and immune checkpoint inhibitors that are used in clinical settings in addition to …
and immune checkpoint inhibitors that are used in clinical settings in addition to …
Anticancer drug therapy for patients with renal dysfunction.
K Suyama, Y Miura - International Journal of Clinical …, 2023 - search.ebscohost.com
Anticancer drug therapy for cancer is developing rapidly, including molecular-targeted drugs
and immune checkpoint inhibitors that are used in clinical settings in addition to …
and immune checkpoint inhibitors that are used in clinical settings in addition to …
Anticancer drug therapy for patients with renal dysfunction
K Suyama, Y Miura - International Journal of Clinical Oncology, 2023 - search.proquest.com
Anticancer drug therapy for cancer is developing rapidly, including molecular-targeted drugs
and immune checkpoint inhibitors that are used in clinical settings in addition to …
and immune checkpoint inhibitors that are used in clinical settings in addition to …